Testing effectiveness (Phase 2)Study completedNCT03689543What this trial is testingEstrogen Receptor Beta and MoodWho this might be right forPerimenopause-Related Depression National Institute of Mental Health (NIMH) 74
Testing effectiveness (Phase 2)Study completedNCT00134680What this trial is testingLetrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBCWho this might be right forMetastatic Breast Cancer Duke University 33
Early research (Phase 1)Active Not RecruitingNCT05870579What this trial is testing[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast CancerWho this might be right forBreast Cancer Novartis Pharmaceuticals 28
Large-scale testing (Phase 3)Looking for participantsNCT07062965What this trial is testingLearn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Who this might be right forBreast Cancer Pfizer 400
Testing effectiveness (Phase 2)Study completedNCT00338728What this trial is testingLetrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveKIT Positive+4 more M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT01783444What this trial is testingA Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.Who this might be right forBreast Cancer Novartis Pharmaceuticals 309
Large-scale testing (Phase 3)Study completedNCT00396565What this trial is testingEvaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With SchizophreniaWho this might be right forSchizophrenia Janssen Pharmaceutical K.K. 394
Post-approval studies (Phase 4)Study completedNCT06995144What this trial is testingComparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart FailureWho this might be right forHeart FailureEdemaPulmonary Congestion+1 more Sarfez Pharmaceuticals, Inc. 20
Not applicableStudy completedNCT03946904What this trial is testingClinical Study of Laser Analgesia in Cavity Preparations Using the Er,Cr:YSGG LaserWho this might be right forTooth Pain Chen Laser Institute 48
Early research (Phase 1)Study completedNCT04541433What this trial is testingAZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast CancerWho this might be right forER+ HER2- Advanced Breast Cancer AstraZeneca 10
Not applicableStudy completedNCT03200392What this trial is testingEr,Cr:YSGG Laser For Recipient Bed Bio-modification And Connective Tissue Harvesting in Treatment of Gingival RecessionWho this might be right forGingival Recession, Localized Misr International University 24
Not applicableLooking for participantsNCT07214532What this trial is testingSignatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerWho this might be right forBreast NeoplasmsCarcinoma, Ductal, BreastReceptors, Estrogen (for ER-positive Requirement) Natera, Inc. 725
Large-scale testing (Phase 3)Study completedNCT00195741What this trial is testingThe Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in AdolescentsWho this might be right forMigraine Abbott 300
Not applicableLooking for participantsNCT06707441What this trial is testingThorax vs. Trauma Injury Severity Scores as Outcome Predictors in Chest TraumaWho this might be right forChest Trauma Al-Nahrain University 150
Large-scale testing (Phase 3)Study completedNCT00062556What this trial is testingEffect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent ClaudicationWho this might be right forIntermittent ClaudicationPeripheral Vascular Disease Kos Pharmaceuticals 366
Not applicableStudy completedNCT00115505What this trial is testingQuality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast CancerWho this might be right forBreast Carcinoma Alliance for Clinical Trials in Oncology 307
Large-scale testing (Phase 3)UnknownNCT04753177What this trial is testingThe Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast CancerWho this might be right forThe Neoadjuvant Therapy Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary 120
Early research (Phase 1)Study completedNCT02261103What this trial is testingBioavailability of Increasing Pramipexole Doses of Oral Extended Release (ER) Tablets in Healthy Male VolunteersWho this might be right forHealthy Boehringer Ingelheim 39
Testing effectiveness (Phase 2)Ended earlyNCT00661531What this trial is testingEstrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine TherapyWho this might be right forBreast CancerCancer of the BreastNeoplasms, Breast Georgetown University 11
Testing effectiveness (Phase 2)Study completedNCT02260531What this trial is testingCabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain MetastasesWho this might be right forBreast CancerBrain Tumor - Metastatic Dana-Farber Cancer Institute 36